Related Experiment Video
Updated: Oct 3, 2025

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage
Ajay Major1, Monica Palese2, Ebru Ermis2
1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL.
Insights
Global pediatric cancer research collaboration requires tailored strategies, recognizing diverse regional needs and structures. A nuanced approach, incorporating local insights and grassroots efforts, is essential for advancing the WHO Global Initiative for Childhood Cancer.
Area of Science:
- Pediatric Oncology
- Global Health
- Clinical Research Collaboration
Background:
- The global pediatric oncology landscape, especially in high-burden regions like Africa, Asia, and Central/South America, is under-documented.
- Understanding existing international pediatric cancer clinical trial groups is crucial for global research and data-sharing initiatives.
Purpose of the Study:
- To review the formation and research pursuits of international pediatric cancer clinical trial groups.
- To inform global collaborative research efforts aligned with the WHO Global Initiative for Childhood Cancer.
Main Methods:
- A narrative literature review was conducted on collaborative pediatric cancer clinical research groups across continents.
- An inventory of these groups was compiled and reviewed by regional and continental leaders.
- Common structural and research themes among consortia were identified.
Main Results:
- Significant variability exists in the structure, history, and objectives of international pediatric cancer clinical trial groups.
- Some regions feature established groups with adapted treatment regimens, while others focus on registry infrastructure via multinational support or partnerships.
Conclusions:
- A one-size-fits-all approach to international collaboration is ineffective due to varying local needs and resources.
- Needs assessments, grassroots approaches, twinning relationships, and implementation science are vital for successful global partnerships in pediatric cancer research.
Purpose:
The global pediatric oncology clinical research landscape, particularly in Central and South America, Africa, and Asia, which bear the highest burden of global childhood cancer cases, is less characterized in the literature. Review of how existing pediatric cancer clinical trial groups internationally have been formed and how their research goals have been pursued is critical for building global collaborative research and data-sharing efforts, in line with the WHO Global Initiative for Childhood Cancer.
Methods:
A narrative literature review of collaborative groups performing pediatric cancer clinical research in each continent was conducted. An inventory of research groups was assembled and reviewed by current pediatric cancer regional and continental leaders. Each group was narratively described with identification of common structural and research themes among consortia.
Results:
There is wide variability in the structure, history, and goals of pediatric cancer clinical trial collaborative groups internationally. Several continental regions have longstanding endogenously-formed clinical trial groups that have developed and published numerous adapted treatment regimens to improve outcomes, whereas other regions have consortia focused on developing foundational database registry infrastructure supported by large multinational organizations or twinning relationships.
Conclusion:
There cannot be a one-size-fits-all approach to increasing collaboration between international pediatric cancer clinical trial groups, as this requires a nuanced understanding of local stakeholders and resources necessary to form partnerships. Needs assessments, performed either by local consortia or in conjunction with international partners, have generated productive clinical trial infrastructure. To achieve the goals of the Global Initiative for Childhood Cancer, global partnerships must be sufficiently granular to account for the distinct needs of each collaborating group and should incorporate grassroots approaches, robust twinning relationships, and implementation science.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Treatment Resistant Cancers
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

